Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 4, 1998
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerizationR Gastpar, M Goldbrunner, D Marko, et al.Archiv Der Pharmazie|July 1, 1990
3-(Cyclohexenonyl)-4-(4-hydroxyphenyl)-hexanes: antiandrogenes derived from the estrogen hexestrolC D Schiller, M R Schneider, E von AngererJournal of Medicinal Chemistry|September 1, 1990
1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonistsE von Angerer, N Knebel, M Kager, et al.Archiv Der Pharmazie|October 1, 1991
6,7-Dihydro-4H-indolones: synthesis and biological propertiesC D Schiller, E von Angerer, M R SchneiderJournal of Cancer Research and Clinical Oncology|January 1, 1980
[Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)]G Kranzfelder, M Schneider, E von Angerer, et al.Journal of Medicinal Chemistry|August 1, 1980
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanesR W Hartmann, G Kranzfelder, E von Angerer, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1992
Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluationM Kager, T Spruss, M R Schneider, et al.The Journal of Endocrinology|September 1, 1991
Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and miceY Nishino, M R Schneider, H Michna, et al.Journal of Medicinal Chemistry|September 1, 1984
Benzylamines: synthesis and evaluation of antimycobacterial propertiesW R Meindl, E von Angerer, H Schönenberger, et al.European Journal of Cancer & Clinical Oncology|July 1, 1987
Antitumor activity of antiestrogenic phenylindoles on experimental prostate tumorsM R Schneider, E von Angerer, W Höhn, et al.Pageof 7